Analysts Conflicted on These Healthcare Names: Hookipa Pharma (HOOK), Olink Holding (OLK) and Pfizer (PFE)
August 23 2022 - 12:41AM
TipRanks
Analysts have been eager to weigh in on the Healthcare sector with
new ratings on Hookipa Pharma (HOOK – Research Report), Olink
Holding (OLK – Research Report) and Pfizer (PFE – Research Report).
Hookipa Pharma (HOOK) SVB Securities analyst Andrew Berens
maintained a Buy rating on Hookipa Pharma yesterday. The company's
shares closed last Monday at $1.55, close to its 52-week low of
$1.25. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-hookipa-pharma-hook-olink-holding-olk-and-pfizer-pfe?utm_source=advfn.com&utm_medium=referral
HOOKIPA Pharma (NASDAQ:HOOK)
Historical Stock Chart
From Dec 2022 to Jan 2023
HOOKIPA Pharma (NASDAQ:HOOK)
Historical Stock Chart
From Jan 2022 to Jan 2023